SCHEMBL22280900

SCHEMBL22280900

Cc1nn2c(N3CCOCC3)c(C(=O)N[C@H]3CCOc4ccccc43)cnc2c1-c1c(F)ccc(Cl)c1F

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ TP53 P04637 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ CNR1 P21554 1/20 0.36
▸ CNR2 P34972 1/20 0.36
▸ BRD4 O60885 2/20 0.36
▸ CREBBP Q92793 2/20 0.36
▸ MAPK1 P28482 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ HSP90AA1 P07900 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ P2RX7 Q99572 1/20 0.35
▸ PDE2A O00408 1/20 0.34
▸ THRB P10828 1/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.34
▸ NTRK1 P04629 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22280901 0.94 HPGD (0.39) ALDH1A1HPGDTP53POLBCNR1
SCHEMBL22281225 0.88 BRD4 (0.37) BRD4CREBBPMAPK1MAPTP2RX7
SCHEMBL22280906 0.87 MAPK1 (0.36) ALDH1A1HPGDTP53CNR1CNR2
SCHEMBL22280903 0.86 MAPK1 (0.36) ALDH1A1HPGDCNR1CNR2BRD4
SCHEMBL22280899 0.85 MEN1 (0.40) ALDH1A1TP53POLBCNR1CNR2
SCHEMBL22281411 0.83 BRD4 (0.36) BRD4CREBBPMAPK1MAPTP2RX7
SCHEMBL19492768 0.82 HSP90AA1 (0.40) TP53CNR1CNR2BRD4CREBBP
SCHEMBL22281226 0.82 PDE2A (0.37) BRD4CREBBPMAPK1MAPTPDE2A
SCHEMBL23355445 0.81 P2RX7 (0.40) ALDH1A1HPGDCNR1CNR2BRD4
SCHEMBL30933444 0.81 P2RX7 (0.40) ALDH1A1HPGDCNR1CNR2BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11001590-B2 Pyrazolopyrimidine derivatives BAYER ANIMAL HEALTH GMBH (DE) 2021-05-11 — — US disclosed
US-10934301-B2 Pyrazolopyrimidine derivatives BAYER ANIMAL HEALTH GMBH (DE) 2021-03-02 — — US disclosed
US-20200299299-A1 NEW PYRAZOLOPYRIMIDINE DERIVATIVES BAYER ANIMAL HEALTH GMBH (DE) 2020-09-24 — — US disclosed
US-20200239482-A1 PYRAZOLOPYRIMIDINE DERIVATIVES BAYER ANIMAL HEALTH GMBH (DE) 2020-07-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11001590-B2 Pyrazolopyrimidine derivatives P2RX5, RECQL, P2RX1 ALDH1A1 1228/4885HPGD 300/4885TP53 2133/4885
US-20200239482-A1 PYRAZOLOPYRIMIDINE DERIVATIVES P2RX5, RECQL, P2RX1 ALDH1A1 1228/4885HPGD 300/4885TP53 2133/4885
US-10934301-B2 Pyrazolopyrimidine derivatives P2RX5, RECQL, P2RX1 ALDH1A1 1228/4885HPGD 300/4885TP53 2133/4885
US-20200299299-A1 NEW PYRAZOLOPYRIMIDINE DERIVATIVES P2RX5, RECQL, P2RX1 ALDH1A1 1241/4885HPGD 319/4885TP53 2346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback